Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,876 | -3,957 | N/A | -4,220 | N/A |
| Depreciation Amortization | 23 | 1 | N/A | 8 | N/A |
| Accounts payable and accrued liabilities | 64 | -56 | N/A | -265 | N/A |
| Other Working Capital | -221 | -450 | N/A | -807 | N/A |
| Other Operating Activity | 258 | 426 | 0 | 239 | 0 |
| Operating Cash Flow | $-4,752 | $-4,036 | $N/A | $-5,045 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,000 | 4,500 | N/A | -1,000 | N/A |
| PPE Investments | -1 | -4 | N/A | -2 | N/A |
| Investing Cash Flow | $2,999 | $4,496 | $N/A | $-1,002 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,373 | N/A | N/A | 6,527 | N/A |
| Financing Cash Flow | $3,373 | $N/A | $N/A | $6,527 | $N/A |
| Exchange Rate Effect | 9 | -19 | N/A | N/A | N/A |
| Beginning Cash Position | 4,825 | 4,278 | N/A | 2,978 | N/A |
| End Cash Position | 6,454 | 4,719 | N/A | 3,458 | N/A |
| Net Cash Flow | $1,629 | $441 | $N/A | $480 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,752 | -4,036 | N/A | -5,045 | N/A |
| Capital Expenditure | -1 | -4 | N/A | -2 | N/A |
| Free Cash Flow | -4,753 | -4,040 | 0 | -5,047 | 0 |